Lasers in surgery and medicine · 2026
Clinical and Histopathological Assessment of the Field of Cancerization in Human Skin Before and After Treatment With a 1927-nm Thulium Fractional Laser.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Salviano Livia Maria Oliveira, Hirayama André Bubna, Pincelli Marcella Soares, Arruda Vivian Nunes, Davanço Rodrigo Cesar, Pinto Luiza Reis, Ribeiro Torezan Luis Antonio
Аннотация
BACKGROUND: Field cancerization is a major concern in photodamaged skin due to its risk of progression to squamous cell carcinoma. The 1927-nm thulium laser has emerged as a promising therapy, but its isolated effects on this condition remain underexplored.
OBJECTIVE: To evaluate clinical and histopathological changes in field cancerization treated with the 1927-nm thulium laser.
METHODS: It was a prospective, observational, and interventional clinical study. Twenty-three patients (age average of 61.3 years), phototype I-III, with facial photodamage and multiple actinic keratosis underwent 4 monthly sessions of thulium laser, followed by a 3-month evaluation. Outcomes included lesion counts and a photoaging scale at each session, along with comprehensive histological analysis of pre- and post-treatment biopsies from 20 patients.
RESULTS: There was a significant reduction in AK count (p < 0.001) and photoaging parameters (p < 0.001). Histologically, we observed improvement in vertical extension of keratinocyte atypia (p = 0.046), increased dermal thickness (p = 0.012), and fibroplasia (p < 0.001). No severe adverse effects occurred.
CONCLUSION: The 1927-nm thulium laser is a safe, well-tolerated and has promising results as a field-directed therapy for actinic keratosis, promoting both clinical and histopathological improvement.
OBJECTIVE: To evaluate clinical and histopathological changes in field cancerization treated with the 1927-nm thulium laser.
METHODS: It was a prospective, observational, and interventional clinical study. Twenty-three patients (age average of 61.3 years), phototype I-III, with facial photodamage and multiple actinic keratosis underwent 4 monthly sessions of thulium laser, followed by a 3-month evaluation. Outcomes included lesion counts and a photoaging scale at each session, along with comprehensive histological analysis of pre- and post-treatment biopsies from 20 patients.
RESULTS: There was a significant reduction in AK count (p < 0.001) and photoaging parameters (p < 0.001). Histologically, we observed improvement in vertical extension of keratinocyte atypia (p = 0.046), increased dermal thickness (p = 0.012), and fibroplasia (p < 0.001). No severe adverse effects occurred.
CONCLUSION: The 1927-nm thulium laser is a safe, well-tolerated and has promising results as a field-directed therapy for actinic keratosis, promoting both clinical and histopathological improvement.